InterventiOnal Study of Bone and Joint Infections Related Gut dysbiosIS (OSIRIS)
Sponsor: MaaT Pharma
This NA trial investigates Bone and Joint Infection and is currently completed. MaaT Pharma leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
May 2018 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 3 earlier versions
-
Dec 2017 — May 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2017 — Dec 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Jun 2017 [monthly]
Not Yet Recruiting NA
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MaaT Pharma
For direct contact, visit the study record on ClinicalTrials.gov .